21
Participants
Start Date
November 15, 2017
Primary Completion Date
June 13, 2019
Study Completion Date
July 9, 2019
BION-1301
a solution for intravenous (IV) administration, diluted and administered Q2W
UPMC (University of Pittsburgh Medical Center) Hillman Cancer Center, Pittsburgh
Virginia Cancer Specialists, Fairfax
Winship Cancer Institute/Emory University, Atlanta
Ohio State University Wexner Medical Center James Cancer Hospital, Columbus
Froedtert Hospital & The Medical College of Wisconsin, Milwaukee
James R. Berenson, MD, Inc, West Hollywood
Swedish Medical Center, Seattle
Lead Sponsor
Chinook Therapeutics, Inc.
INDUSTRY